Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.
about
Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo.Preclinical evaluation of herpes simplex virus armed with granulocyte-macrophage colony-stimulating factor in pancreatic carcinoma
P2860
Increased anti-tumor effect by a combination of HSV thymidine kinase suicide gene therapy and interferon-gamma/GM-CSF cytokine gene therapy in CT26 tumor model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@en
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@nl
type
label
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@en
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@nl
prefLabel
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@en
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@nl
P2093
P2860
P921
P1476
Increased anti-tumor effect by ...... e therapy in CT26 tumor model.
@en
P2093
Seung Taik Kim
Sung Hyun Yang
Tae Keun Oh
P2860
P304
P356
10.3346/JKMS.2005.20.6.932
P577
2005-12-01T00:00:00Z